Qube Research & Technologies (QRT)’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-122,155
Closed -$2.12M 4023
2024
Q1
$2.12M Hold
122,155
﹤0.01% 1719
2023
Q4
$1.97M Hold
122,155
﹤0.01% 1536
2023
Q3
$1.81M Buy
122,155
+11,045
+10% +$170K ﹤0.01% 1434
2023
Q2
$1.74M Buy
111,110
+16,874
+18% +$261K 0.01% 1096
2023
Q1
$1.47M Buy
94,236
+19,463
+26% +$284K 0.01% 1141
2022
Q4
$1M Buy
+74,773
New +$1.02M 0.01% 1223

Other funds holding ECAT

Qube Research & Technologies (QRT)'s ECAT Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q2 2024, closing a stake of 122,155 shares — an estimated $2.12M sold.

Qube Research & Technologies (QRT) first reported a position in ECAT in Q4 2022 and held it in 6 quarters. The position peaked at $2.12M in Q1 2024. 63 funds tracked by Wall St. Rank hold ECAT as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 122,155 BlackRock ESG Capital Allocation Term Trust shares in Q2 2024, an estimated $2.12M.
  • Qube Research & Technologies (QRT) first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s BlackRock ESG Capital Allocation Term Trust position peaked at $2.12M in Q1 2024.
  • 63 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.